Split Creek Capital’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Split Creek Capital's NVS Position: Q3 2026 in Review
Split Creek Capital reduced its Novartis (NVS) stake by 6.3% in Q3 2026, selling an estimated $36.3K and leaving 3,552 shares worth $506K. The position accounts for 0.48% of the portfolio, ranked #68.
Split Creek Capital first reported a position in NVS in Q4 2025 and has held it in 4 quarters since. The position peaked at $594K in Q2 2026. 1,370 funds tracked by Wall St. Rank hold NVS as of Q3 2026.
- Split Creek Capital held 3,552 shares of Novartis worth $506K as of Q3 2026.
- Split Creek Capital sold 239 Novartis shares in Q3 2026, an estimated $36.3K.
- Novartis made up 0.48% of Split Creek Capital's portfolio in Q3 2026, its #68 holding.
- Split Creek Capital first reported a position in Novartis in Q4 2025 and has held it in 4 quarters since.
- Split Creek Capital's Novartis position peaked at $594K in Q2 2026.
- 1,370 funds tracked by Wall St. Rank held Novartis as of Q3 2026.
Based on Split Creek Capital's 13F filing for Q3 2026, filed 2 Nov 2026.